ISRCTN Registry, ResearchGate 2 Glucose control & metabolic markers in type 2 diabetes / pre-diabetes 14 g/day for 852 weeks 2024 dose-response meta-analysis of 36 RCTs (n=3 214) found clinically meaningful reductions in fasting glucose (9 mg/dL), HbA1c (0.32 %) and HOMA-IR (0.43)
We now have powerful classes of drugs that not only lower glucose but also protect your heart and help with weight loss
Chronic Fatigue : If you feel drained, IV therapy can provide a quick energy boost
Not intended for diagnostic, therapeutic, cosmetic, or clinical applications
This is completely normal and is a sign that the active ingredient is present
Store in a dry environment, in a well-closed container at a temperature of up to 25C, out of reach of small children